Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

698 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Ten-Year Clinical Outcomes of Biodegradable Versus Durable Polymer New-Generation Drug-Eluting Stent in Patients With Coronary Artery Disease With and Without Diabetes Mellitus.
Lenz T, Koch T, Joner M, Xhepa E, Wiebe J, Coughlan JJ, Aytekin A, Ibrahim T, Fusaro M, Cassese S, Laugwitz KL, Schunkert H, Kastrati A, Kufner S; ISAR‐TEST 4 (Intracoronary Stenting, Angiographic Results: Test Efficacy of 3 Limus‐Eluting Stents) Investigators †. Lenz T, et al. J Am Heart Assoc. 2021 Jun 15;10(12):e020165. doi: 10.1161/JAHA.120.020165. Epub 2021 Jun 2. J Am Heart Assoc. 2021. PMID: 34075784 Free PMC article. Clinical Trial.
ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting.
Schulz-Schüpke S, Byrne RA, Ten Berg JM, Neumann FJ, Han Y, Adriaenssens T, Tölg R, Seyfarth M, Maeng M, Zrenner B, Jacobshagen C, Mudra H, von Hodenberg E, Wöhrle J, Angiolillo DJ, von Merzljak B, Rifatov N, Kufner S, Morath T, Feuchtenberger A, Ibrahim T, Janssen PW, Valina C, Li Y, Desmet W, Abdel-Wahab M, Tiroch K, Hengstenberg C, Bernlochner I, Fischer M, Schunkert H, Laugwitz KL, Schömig A, Mehilli J, Kastrati A; Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) Trial Investigators. Schulz-Schüpke S, et al. Among authors: schomig a. Eur Heart J. 2015 May 21;36(20):1252-63. doi: 10.1093/eurheartj/ehu523. Epub 2015 Jan 23. Eur Heart J. 2015. PMID: 25616646 Clinical Trial.
Randomized comparison of biolimus-eluting stents with biodegradable polymer versus everolimus-eluting stents with permanent polymer coatings assessed by optical coherence tomography.
Tada T, Kastrati A, Byrne RA, Schuster T, Cuni R, King LA, Cassese S, Joner M, Pache J, Massberg S, Schömig A, Mehilli J. Tada T, et al. Among authors: schomig a. Int J Cardiovasc Imaging. 2014 Mar;30(3):495-504. doi: 10.1007/s10554-014-0376-1. Epub 2014 Jan 23. Int J Cardiovasc Imaging. 2014. PMID: 24452729 Clinical Trial.
Prognostic value of late gadolinium enhancement in cardiovascular magnetic resonance imaging after acute ST-elevation myocardial infarction in comparison with single-photon emission tomography using Tc99m-Sestamibi.
Hadamitzky M, Langhans B, Hausleiter J, Sonne C, Byrne RA, Mehilli J, Kastrati A, Schömig A, Martinoff S, Ibrahim T. Hadamitzky M, et al. Among authors: schomig a. Eur Heart J Cardiovasc Imaging. 2014 Feb;15(2):216-25. doi: 10.1093/ehjci/jet176. Epub 2013 Nov 14. Eur Heart J Cardiovasc Imaging. 2014. PMID: 24243144
Three-dimensional echocardiographic optimization improves outcome in cardiac resynchronization therapy compared to ECG optimization: a randomized comparison.
Sonne C, Bott-Flugel L, Hauck S, Hadamitzky M, Lesevic H, Demetz G, Braun D, Wolf P, Hausleiter J, Schömig A, Kolb C. Sonne C, et al. Among authors: schomig a. Pacing Clin Electrophysiol. 2014 Mar;37(3):312-20. doi: 10.1111/pace.12281. Epub 2013 Oct 25. Pacing Clin Electrophysiol. 2014. PMID: 24164640 Clinical Trial.
698 results